HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of inflammatory bowel disease in adults and children: evaluation of a new isotopic technique.

Abstract
The distribution of radioactivity after the oral administration of sucralfate labelled with technetium-99m was studied in 33 patients with Crohn's disease (13 adults, 20 children), 10 with ulcerative colitis (four adults), and 29 controls (23 with upper intestinal disease, four irritable bowel, one hypolactasia, and one malrotation of the gut). Positive scans were obtained in all patients with ulcerative colitis and 29 of 31 with active Crohn's disease. The scans of two patients with inactive Crohn's disease were negative. There were two false negative scans in patients with Crohn's colitis and one false positive scan. Overall, sensitivity was 95% and specificity 97%. Comparison with radiology in 39 patients showed similar distribution of disease in 24 and more extensive disease in 12. The scan was inexpensive, simple to perform, well tolerated, allowed small and large bowel to be visualised simultaneously, and used a lower dose of radiation than barium studies. It may prove useful as a screening test for inflammatory bowel disease and in the serial assessment of disease activity.
AuthorsD J Dawson, A N Khan, V Miller, J F Ratcliffe, D R Shreeve
JournalBritish medical journal (Clinical research ed.) (Br Med J (Clin Res Ed)) Vol. 291 Issue 6504 Pg. 1227-30 (Nov 02 1985) ISSN: 0267-0623 [Print] England
PMID3933613 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Organotechnetium Compounds
  • technetium Tc 99m sucralfate
  • Sucralfate
  • Technetium
  • Aluminum
Topics
  • Administration, Oral
  • Adult
  • Aluminum (administration & dosage)
  • Child
  • Colitis, Ulcerative (diagnostic imaging)
  • Crohn Disease (diagnostic imaging)
  • False Negative Reactions
  • False Positive Reactions
  • Humans
  • Organotechnetium Compounds
  • Radiation Dosage
  • Radiography
  • Radionuclide Imaging
  • Sucralfate
  • Technetium (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: